Further analysis revealed that Pygo2+ CD8+ T cells primarily engage with tumor cells and macrophages through immune checkpoint receptor-ligand pairs, such as CD74, CD55, and SPP1 (Supplementary Figure S5). Here, PYGO2 is linked to neoplasm.